Skip to main content
. 2012 Jun;56(6):3114–3120. doi: 10.1128/AAC.00384-12

Table 4.

Relapse rates assessed 3 months after treatment completion in experiment 2

Drug regimen Proportion (%) relapsing after treatment for:
4 wks 6 wks 8 wks 10 wks
RPT + PZA + MXF NDa ND 7/15 (47) 2/15 (13)
TMC + PZA ND 14/15 (93) 10/15 (67) 8/15 (53)
TMC + PZA + RPT ND 5/15 (33) 0/15 (0) ND
TMC + PZA + CFZ ND 1/15 (7) 0/15 (0) ND
TMC + PZA + PNU ND 8/15 (53) 6/15 (40) ND
TMC + PZA + RPT + CFZ 4/15 (27) 0/15 (0) ND ND
a

ND, not done.